Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Rheumatoid Arthritis Patient Shares Lessons Learned from Breaking Leg in a Fall

Sarah Troxell, RN, BSN  |  September 8, 2016

Humpty Dumpty sat on a wall Humpty Dumpty had a great fall All the king’s horses and all the king’s men Couldn’t put Humpty together again. —Mother Goose I feel like a female Humpty Dumpty. Recently I took a great fall, and now I am in the process of being put together again. I was…

Filed under:ConditionsPatient PerspectiveRheumatoid Arthritis Tagged with:outcomepatient careRheumatoid arthritisrheumatologist

Rheumatology Research Foundation Investigators’ Meeting Shares Advancements Toward a Cure

From the College  |  September 7, 2016

The Rheumatology Research Foundation hosted the 9th annual Investigators’ Meeting in Atlanta on June 24–25. As a requirement for Foundation innovative research and pilot grant recipients, Foundation-funded investigators meet annually to provide updates and status reports on the work they are doing to advance treatments and cures for rheumatic diseases. More than 50 attendees enjoyed…

Filed under:From the CollegeResearch Rheum Tagged with:Advocacycureinvestigatorspatient carerheumatologyRheumatology Research Foundation

The Patient's Choice

When Rheumatologists Are a Patient’s Second or Third Choice for Medical Opinion

Charles Radis, DO  |  September 7, 2016

Outside Exam Room No. 5, the chart rack was empty, so I assumed my new consult was late. Just in case, I looked back over my shoulder as I passed by the partially open door and glimpsed the lower half of a woman holding a three-ringed binder on her lap. I squinted and took a…

Filed under:ConditionsPractice SupportPsoriatic Arthritis Tagged with:ArthritisLyme Diseasepatient carePractice ManagementPsoriatic ArthritisRheumatic Diseaserheumatologist

Tocilizumab Promising for sJIA

Michele B. Kaufman, PharmD, BCGP  |  September 7, 2016

In a clinical trial of pediatric patients, tocilizumab proved safe and effective for treating systemic juvenile idiopathic arthritis…

Filed under:ConditionsDrug UpdatesPediatric Conditions Tagged with:clinical trialsPediatricsJIAsystemic juvenile idiopathic arthritistocilizumab

FDA Approves Etanercept-szzs Biosimilar

Michele B. Kaufman, PharmD, BCGP  |  September 2, 2016

Although it may not be available until 2017, the FDA approved the use of etanercept-szzs for multiple autoimmune diseases…

Filed under:Biologics/DMARDsDrug Updates Tagged with:Biosimilarsetanerceptetanercept-szzsFDAFood and Drug Administration

What Do Patients Know about Biosimilar Drugs?

Lisa Rapaport, Reuters Staff  |  September 1, 2016

(Reuters Health)—Many patients haven’t heard of biosimilars, generic versions of complex biotech drugs, and even some who say they’re familiar with these medicines may still be confused about them, a small European survey suggests.1 To see what patients know about biosimilars, researchers analyzed data from online surveys completed by 1,181 patients with irritable bowel disease…

Filed under:Biologics/DMARDsPatient Perspective Tagged with:Biologics & Biosimilarsbiotech drugspatient knowledge

How to Maintain HIPAA Compliance

Kelly Tyrrell  |  September 1, 2016

In 2010, the federal government published a guide, titled Basic Security for the Small Healthcare Practice, complete with best practices and checklists to help small providers achieve and maintain HIPAA compliance.1 This year, the Department of Health and Human Services (HHS) Office for Civil Rights (OCR)—following a critical report of its HIPAA compliance audit and enforcement…

Filed under:Legal UpdatesPractice SupportProfessional Topics Tagged with:HIPAA auditHIPAA complianceOffice for Civil Rights

Adalimumab Lowers Risk of Uveitic Flare

Will Boggs, MD  |  August 30, 2016

NEW YORK (Reuters Health)—Adalimumab reduces the risk of uveitic flare after corticosteroid withdrawal in patients with inactive, noninfectious uveitis, according to results from VISUAL II. “Tumor-necrosis factor (TNF) inhibition, which has been demonstrated to have strong efficacy in rheumatologic disorders, can also have significant role in the management of noninfectious uveitis, even amidst the challenges…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabeyeInflammatory Eye DiseaseUveitis

Placebo Outperforms Glucosamine/Chondroitin Sulfate for Knee OA

Erin Blakemore  |  August 24, 2016

(Reuters Health)—Glucosamine sulfate and chondroitin sulfate are not more beneficial than placebo treatments for patients with knee osteoarthritis, a recent trial suggests. In a double-blind study, researchers investigated the efficacy of a medicine that delivered both glucosamine and chondroitin sulfate. The 164 participants all had osteoarthritis and moderate to severe knee pain. Half the participants…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis & Rheumatologychondroitin sulfateglucosamine sulfatekneeKnee Osteoarthritis (OA)knee painplacebo

FDA Approves Updated Labeling on Risk of Osteonecrosis of the Jaw for Denosumab

Michele B. Kaufman, PharmD, BCGP  |  August 24, 2016

Denosumab’s labeling now says a patient’s risk of developing osteonecrosis of the jaw may increase with prolonged exposure…

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:bonedenosumabFDAFood and Drug AdministrationOsteonecrosisOsteoporosis

  • « Previous Page
  • 1
  • …
  • 204
  • 205
  • 206
  • 207
  • 208
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences